Not Intended for Therapeutic Use. For research use only.

Talabostat mesylate - CAS 150080-09-4

Quick Inquiry

Name:
* Email:
* Service & Products of Interest:
* Quantity:
* Verification code:
Please input "bocsci" as verification code.
Category
Inhibitor
Product Name
Talabostat mesylate
Catalog Number
150080-09-4
Synonyms
PT-100; D05989; ValboroPro; [(2R)-1-[(2S)-2-Amino-3-methylbutanoyl]pyrrolidin-2-yl]boronic acid mesylate
CAS Number
150080-09-4
Description
Talabostat mesylate is the orally bioavailable mesylate salt of an amino boronic dipeptide with antineoplastic and hematopoiesis- stimulating activities. By cleaving N-terminal Xaa-Pro or Xaa-Ala residues, talabostat inhibits dipeptidyl peptidases, such as fibroblast activation protein (FAP), resulting in the stimulation of cytokine and chemokine production and specific T-cell immunity and T-cell- dependent activity. This agent may also stimulate the production of colony stimulating factors, such as granulocyte colony stimulating factor (G-CSF), resulting in the stimulation of hematopoiesis. Dipeptidyl peptidases are involved in the activation of polypeptide hormones and chemokines.
Molecular Weight
310.17
Molecular Formula
C10H23BN2O6S
Quantity
Milligrams-Grams
Quality Standard
Enterprise Standard
COA
Certificate of Analysis-Talabostat mesylate 150080-09-4 B14QT0822  
MSDS
Inquire
Targets
DPP4
Current Developer
Point Therapeutics
Structure
CAS 150080-09-4 Talabostat mesylate
Specification
Purity
98%
Appearance
Light beige solid
Application
For research used only
Related DPP4 Products
  • CAS 865759-25-7 Trelagliptin

    Trelagliptin
    (CAS: 865759-25-7)

    Two Phase II clinical studies have been completed with Efficacy and Safety of SYR-472 in Subjects With Type 2 Diabetes Mellitus. Phase III clinical studies with...

  • CAS 906093-29-6 Teneligliptin hydrobromide

    Teneligliptin hydrobromide
    (CAS: 906093-29-6)

    Teneligliptin hydrobromide is a novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor. It competitively inhibited human plasma, rat plasma, and human...

  • CAS 945667-22-1 Saxagliptin hydrate

    Saxagliptin hydrate
    (CAS: 945667-22-1)

    Saxagliptin hydrate is a selective and reversible DPP4 inhibitor. It demonstrates greater specificity for DPP4 than for either the DPP8 or DPP9 enzymes. It redu...

  • CAS 654671-78-0 Sitagliptin phosphate

    Sitagliptin phosphate
    (CAS: 654671-78-0)

    Sitagliptin phosphate is a potent inhibitor of DPP4 in Caco-2 cell extracts.

  • CAS 1186426-66-3 DBPR108

    DBPR108
    (CAS: 1186426-66-3)

    DBPR108 is an IC50=15 nM DPP IV inhibitor displays a more than 3000-fold selectivity over DPP8 DPP9, FAP and DPP-II. TThe in vivo effects of DBPR108, including ...

  • ASP-4000 hydrochoride
    (CAS: 851389-35-0)

    ASP-4000 is a dipeptidyl peptidase 4 (DPP) inhibitor. It has antihyperglycemic activity.

  • CAS 850649-62-6 ALOGLIPTIN BENZOATE

    ALOGLIPTIN BENZOATE
    (CAS: 850649-62-6)

    Alogliptin benzoate(SYR 322) is a potent, selective inhibitor of DPP-4 with IC50 of <10 nM, exhibits greater than 10,000-fold selectivity over DPP-8 and DPP-9.

  • ASP-8497 free base
    (CAS: 651055-25-3)

    ASP-8497 free base is a long-acting and potent DPP-IV inhibitor. It improves glucose tolerance through glucose-dependent insulinotropic action via elevation of ...

  • CAS 1226781-44-7 Omarigliptin

    Omarigliptin
    (CAS: 1226781-44-7)

    Omarigliptin is a potent and selective dipeptidyl peptidase 4 (DPP-4) inhibitor to be used as treatment for type 2 diabetes.

  • CAS 486460-32-6 Sitagliptin

    Sitagliptin
    (CAS: 486460-32-6)

    Sitagliptin(MK 0431) is a potent inhibitor of DPP4 with IC50 of 19 nM in Caco-2 cell extracts.

  • ASP-8497
    (CAS: 651055-26-4)

    ASP8497 is a long-acting and potent DPP-IV inhibitor. It improves glucose tolerance through glucose-dependent insulinotropic action via elevation of the GLP-1 l...

  • CAS 869490-23-3 Gosogliptin

    Gosogliptin
    (CAS: 869490-23-3)

    Gosogliptin is a dipeptidyl peptidase IV (DPP-IV) inhibitor. But no development was reported about Phase-II for Type-2 diabetes mellitus.

  • CAS 1029877-94-8 Trelagliptin succinate

    Trelagliptin succinate
    (CAS: 1029877-94-8)

    Trelagliptin is a long acting dipeptidyl peptidase-4 (DPP-4) inhibitor that is being developed for the treatment of type 2 diabetes (T2D).

  • CAS 361442-04-8 Saxagliptin

    Saxagliptin
    (CAS: 361442-04-8)

    Saxagliptin is a drug which was developed for the treatment of respiratory disorders such as asthma and Chronic Obstructive Pulmonary Disease (COPD). It is oral...

  • CAS 760937-92-6 Teneligliptin

    Teneligliptin
    (CAS: 760937-92-6)

    Teneligliptin is a novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor. It competitively inhibited human plasma, rat plasma, and human recombinant ...

  • CAS 274901-16-5 Vildagliptin

    Vildagliptin
    (CAS: 274901-16-5)

    Glyptins are class of oral anti-hyperglycemic agents that inhibit dipeptidyl peptidase 4 (DPP-4), which can act as a serine exopeptidase. ASide from there use i...

  • CAS 852329-66-9 Dutogliptin

    Dutogliptin
    (CAS: 852329-66-9)

    Dutogliptin is a selective and orally active DPP4 inhibitor. It can improve glycaemic control in patients with type 2 diabetes. But phase III clinical trials fo...

  • CAS 868771-57-7 Melogliptin

    Melogliptin
    (CAS: 868771-57-7)

    Melogliptin is a selective dipeptidyl peptidase IV (DPP-IV) inhibitor. But No development was reported about Phase-II for Type-2 diabetes mellitus.

  • CAS 668270-12-0 Linagliptin

    Linagliptin
    (CAS: 668270-12-0)

    A novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes.

  • Evogliptin
    (CAS: 1222102-29-5)

    This active molecular is a selective dipeptidyl peptidase 4 (DPP4) inhibitor under the development of Dong-A. Evogliptin improves insulin resistance and delays ...

2005 - BOC Sciences | All rights reserved
DOWNLOAD